Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 031 390.4 |
| 96 | EP file number | EAKZ | 09 00 4646.7 |
| 97 | EP publication number | EPN | 2077121 |
| 54 | Designation/title | TI | Gerinnungsfaktor VII-Fc chimäre Proteine zur Behandlung von hämostatischen Krankheiten |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/395 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C12P 21/08 (2006.01) |
| 22 | DE application date | DAT | May 6, 2004 |
| 96 | EP application date | EAT | May 6, 2004 |
| 43 | Date of first publication | OT | Jul 8, 2009 |
| Date of publication of grant | PET | Feb 9, 2011 |
| 71/73 | Applicant/owner | INH | Syntonix Pharmaceuticals, Inc., Waltham, Mass., US |
| 72 | Inventor | IN | Rivera, Daniel S., Nonwell, MA 02061, US; Peters, Robert T., West Roxbury, MA 02132, US; Bitonti, Alan J., Acton, MA 01720, US |
| 74 | Representative | VTR | Lauer, Joachim, Dipl.-Phys. Dr.rer.nat., 79837 St. Blasien, DE |
| Address for service | | Lauer, Joachim, Dr., 79837 St. Blasien, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
468837
May 6, 2003
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002077121
Searchable text:
EP000002077121
Original document:
EP000002077121B1
Searchable text:
EP000002077121B1 |
| 43 | Date of first publication | EVT | Jul 8, 2009 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022
(Show all update days)(Hide all update days)- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
